Exhibit 99.2

CRANE CO.

Income Statement Data

(in thousands, except per share data)

	Three Months Ended June 30,						Six Months Ended June 30,
	2005			2004			2005			2004
Net Sales:
Aerospace & Electronics	$	133,940		$	126,436		$	267,521		$	245,713
Engineered Materials		79,194			74,321			159,992			143,331
Merchandising Systems		45,687			42,591			89,440			82,041
Fluid Handling		245,917			217,890			474,468			421,778
Controls		20,967			17,945			41,483			34,698
Intersegment Elimination		(86	)		(76	)		(224	)		(149	)
Total Net Sales	$	525,619		$	479,107		$	1,032,680		$	927,412
Operating Profit:
Aerospace & Electronics	$	18,268		$	23,927		$	34,218		$	44,148
Engineered Materials		18,286			15,782			35,144			31,313
Merchandising Systems		4,052			3,121			7,833			3,595
Fluid Handling		20,033			14,923			32,457			23,649
Controls		1,817			1,237			3,577			2,127
Corporate		(7,558	)		(8,235	)		(16,481	)		(15,400	)
Total Operating Profit		54,898			50,755			96,748			89,432
Interest Income		161			167			502			389
Interest Expense		(5,742	)		(5,687	)		(11,462	)		(12,228	)
Miscellaneous- Net		1,784			37			2,066			(181	)
Income Before Income Taxes		51,101			45,272			87,854			77,412
Provision for Income Taxes		15,427			14,034			27,182			23,998
Net Income	$	35,674		$	31,238		$	60,672		$	53,414
Per Diluted Share Data:
Net Income	$	0.59		$	0.52		$	1.01		$	0.89
Average Diluted Shares Outstanding		60,091			60,042			60,060			60,240
Average Basic Shares Outstanding		59,606			59,214			59,527			59,395
Supplemental Data:
Cost of Sales	$	363,333		$	324,348		$	714,974		$	630,274
Selling, General & Administrative		107,388			104,004			220,958			207,706
Depreciation and Amortization *		14,419			14,831			29,716			28,629

* Amount included within cost of sales and selling, general & administrative costs.

CRANE CO.

Condensed Balance Sheets

(in thousands)

	June 30, 2005		December 31, 2004
ASSETS
Current Assets
Cash and Cash Equivalents	$	59,624	$	50,727
Accounts Receivable		323,044		308,140
Inventories		284,902		284,291
Other Current Assets		58,934		59,648
Total Current Assets		726,504		702,806
Property, Plant and Equipment		271,579		287,596
Insurance Receivable - Asbestos		238,217		245,160
Other Assets		296,768		301,865
Goodwill		568,209		579,081
Total Assets	$	2,101,277	$	2,116,508
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities
Current Maturities of Long-Term Debt and Loans Payable	$	477	$	371
Accounts Payable		148,083		161,477
Current Asbestos Liability		67,800		67,800
Accrued Liabilities		151,396		157,730
Income Taxes		31,435		22,636
Total Current Liabilities		399,191		410,014
Long-Term Debt		292,566		296,592
Deferred Income Taxes		74,082		71,367
Long-Term Asbestos Liability		555,727		581,914
Pension, Postretirement and Other Liabilities		92,290		92,927
Common Shareholders’ Equity		687,421		663,694
Total Liabilities and Shareholders’ Equity	$	2,101,277	$	2,116,508

CRANE CO.

Condensed Statements of Cash Flows

(in thousands)

	Three Months Ended June 30,						Six Months Ended June 30,
	2005			2004			2005			2004
Operating Activities:
Net income	$	35,674		$	31,238		$	60,672		$	53,414
Income from joint venture		(1,384	)		(1,135	)		(2,582	)		(1,668	)
Depreciation and amortization		14,419			14,831			29,716			28,629
Cash used for operating working capital		385			(7,632	)		(44,636	)		(37,106	)
Other		2,155			(205	)		3,133			(2,878	)
Subtotal		51,249			37,097			46,303			40,391
Payments for asbestos-related fees and costs, net		(8,434	)		(4,631	)		(19,258	)		(10,027	)
Refund associated with termination of the Master Settlement Agreement		—			—			9,925			—
Total provided by operating activities		42,815			32,466			36,970			30,364
Investing Activities:
Capital expenditures		(5,800	)		(5,758	)		(11,375	)		(10,902	)
Proceeds from disposition of capital assets		1,126			621			1,381			795
Payments for acquisitions, net		—			—			—			(50,630	)
Total used for investing activities		(4,674	)		(5,137	)		(9,994	)		(60,737	)
Financing Activities:
Dividends paid		(5,965	)		(5,915	)		(11,920	)		(11,868	)
Settlement of treasury shares acquired on the open market		—			(19,282	)		—			(42,748	)
Stock options exercised - net of shares reacquired		115			2,638			1,876			9,180
Repayment of debt, net		(2,741	)		(5,011	)		(4,425	)		(27,754	)
Total used for financing activities		(8,591	)		(27,570	)		(14,469	)		(73,190	)
Effect of exchange rate on cash and cash equivalents		(2,503	)		(497	)		(3,610	)		(612	)
Increase (decrease) in cash and cash equivalents		27,047			(738	)		8,897			(104,175	)
Cash and cash equivalents at beginning of period		32,577			39,081			50,727			142,518
Cash and cash equivalents at end of period	$	59,624		$	38,343		$	59,624		$	38,343

CRANE CO.

Order Backlog

(in thousands)

	June 30, 2005		March 31, 2005		December 31, 2004		June 30, 2004
Aerospace & Electronics	$	370,913	$	367,472	$	341,505	$	353,087
Engineered Materials		15,964		19,414		16,376		16,197
Merchandising Systems		9,298		9,469		11,998		11,024
Fluid Handling		201,768		200,578		183,158		172,120
Controls		14,952		15,625		13,696		13,451
Total Backlog	$	612,895	$	612,558	$	566,733	$	565,879

CRANE CO.

Non-GAAP Financial Measures

(in thousands)

	Three Months Ended June 30,						Six Months Ended June 30,						Year Ended December 31,
	2005			2004			2005			2004			2005
													(Estimated Range)
Cash provided from operating activities including asbestos-related payments	$	42,815		$	32,466		$	36,970		$	30,364		$	135,000		$	115,000
Net asbestos payments		8,434			4,631			19,258			10,027			40,000			60,000
Refund associated with termination of the Master Settlement Agreement		—			—			(9,925	)		—			—			—
Cash provided from operating activities before asbestos-related payments	$	51,249		$	37,097		$	46,303		$	40,391		$	175,000		$	175,000
Capital expenditures		(5,800	)		(5,758	)		(11,375	)		(10,902	)		(25,000	)		(25,000	)
Free cash flow	$	45,449		$	31,339		$	34,928		$	29,489		$	150,000		$	150,000

	Three Months Ended Sept 30, 2004
(Loss) earnings per share	$	(3.48	)
Asbestos and environmental charge - net of tax		4.04
Earnings per share before charge	$	0.56

Certain non-GAAP measures have been provided to facilitate comparisons with the prior year.

Free cash flow provides supplemental information to assist management and certain investors in analyzing the Company’s ability to generate positive cash flow.

Free cash flow is considered a measure of cash generation and should be considered in addition to, but not as a substitute for, other measures reported in accordance with generally accepted accounting principles and may be inconsistent with similar measures presented by other companies.